Mogito Open Access Journals of Oncology & Cancer Studies (MJOCS) Editorial Policy

At the Mogito Open Access Journal of Oncology and Cancer Studies (MJOCS), our editorial policy embodies a steadfast dedication to oncological excellence, clinical innovation, and the highest standards of scientific integrity. MJOCS operates within a rigorous editorial framework that prioritizes peer-reviewed precision, ethical cancer research, open access dissemination, and global knowledge-sharing.

Our commitment spans the full scope of modern oncology — from molecular diagnostics, targeted therapies, and immuno-oncology to cancer prevention, epidemiology, survivorship, and public health policy — ensuring every published article contributes meaningfully to the advancement of cancer science and patient outcomes worldwide.

Together with our Editorial Board and global network of reviewers, MJOCS maintains a platform where transparency, credibility, and academic rigor drive the publication of impactful cancer research, in pursuit of better care, deeper understanding, and equitable treatment access for all.

Mogito Open Access Journal of Oncology and Cancer Studies (MJOCS)

1. Scope of Content

MJOCS publishes high-quality, peer-reviewed content that advances the science, research, and clinical care of oncology and cancer studies across all cancer types and specialties. The journal accepts:

  • Original research articles

  • Systematic reviews and meta-analyses

  • Clinical trials and translational studies

  • Technical notes and innovations in oncology

  • Case reports and case series

  • Editorials, perspectives, and correspondence

MJOCS welcomes submissions addressing:

  • Cancer biology, genetics, and molecular oncology

  • Oncology therapeutics, immunotherapy, and targeted treatments

  • Early detection, diagnostics, and biomarkers

  • Radiation, surgical, and medical oncology

  • Cancer prevention, screening, and epidemiology

  • Psychosocial oncology, palliative care, and survivorship

  • Global oncology and health disparities

  • Ethics, policy, and outcomes in cancer care

2. Peer Review Process

All manuscripts submitted to MJOCS undergo a double-blind peer review process to ensure objective and rigorous evaluation. Submissions are reviewed by at least two independent experts based on:

  • Scientific soundness and methodological rigor

  • Relevance to oncology and translational impact

  • Innovation and contribution to cancer research

  • Clinical utility and patient care implications

  • Clarity and quality of writing

In cases of conflicting reviews, a third reviewer or a senior editor may provide additional input. Authors are expected to revise according to reviewer feedback. Final decisions rest with the editorial board and are fair, timely, and confidential.

3. Authorship & Contributions

MJOCS follows the ICMJE authorship criteria. All listed authors must contribute significantly in one or more of the following areas:

  • Study design or conceptualization

  • Data collection, analysis, or interpretation

  • Drafting or revising the manuscript

  • Final approval of the version to be published

  • Responsibility for the integrity of the work

Author contributions must be declared during submission. Guest or ghost authorship is strictly prohibited.

4. Ethical Standards

MJOCS adheres to COPE (Committee on Publication Ethics) guidelines. All manuscripts must include:

  • Institutional ethics approval for human or animal research

  • Informed consent for any identifiable patient data or images

  • Declaration of conflicts of interest

  • No plagiarism, duplicate publication, or data fabrication

Violations will be investigated thoroughly and may lead to retraction or institutional reporting.

5. Open Access Policy

MJOCS is a fully open access journal. All content is published under a Creative Commons Attribution License (CC BY 4.0), enabling unrestricted reuse, distribution, and adaptation with proper citation.

6. Data Transparency & Availability

Authors are encouraged to include a data availability statement and share datasets supporting their findings. Exceptions are allowed for privacy or legal concerns. Data transparency enhances reproducibility and scientific credibility.

7. Corrections, Retractions & Expressions of Concern

MJOCS is committed to preserving the accuracy of the scientific record. The journal will issue:

  • Corrections for minor factual errors

  • Retractions for confirmed ethical or scientific misconduct

  • Expressions of Concern when major issues are unresolved

These notices will be clearly linked to the original articles.

8. Editorial Independence

MJOCS maintains complete editorial independence. Editorial decisions are made free from commercial, institutional, or sponsor influence. Editors and reviewers are chosen based on expertise, objectivity, and integrity. The journal does not permit advertising that may compromise editorial judgment.

9. Appeals & Complaints

Authors may appeal editorial decisions with a reasoned response. Appeals are reviewed by a senior editorial committee. Ethical concerns and complaints are handled confidentially and according to COPE recommendations.

10. Indexing and Archiving

MJOCS actively seeks inclusion in recognized indexing platforms, including:

  • Directory of Open Access Journals (DOAJ)

  • Scopus

  • PubMed Central

All published articles are archived digitally to ensure long-term accessibility and citation reliability.

Contact

For editorial policy inquiries or concerns, please contact:
editors_mjocs@mogitojournals.org
www.mogitojournals.org

Call for Editors

Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS), we are proud to collaborate with a distinguished team of scholars, researchers, and healthcare professionals from around the world. Our Editorial Board Members bring deep expertise across the full spectrum of oncology from cancer biology and diagnostics to therapeutic advancements, clinical trials, survivorship, and palliative care.

Together, they uphold the highest standards of peer review, scientific integrity, and ethical publishing, ensuring that MJOCS remains a trusted platform for advancing cancer research and improving patient outcomes globally.

Join Our Editorial Team

We are currently expanding our Editorial Board and warmly invite qualified professionals in oncology, cancer research, and related fields to apply. If you are passionate about scientific publishing, cancer innovation, and global access to knowledge, we encourage you to become part of our editorial mission.

Interested applicants should send a brief statement of interest and CV to:
editors_mjocs@mogitojournals.org

Dr. Grace N. Adebayo

Editor in Chief

Professor of Oncology | Global Cancer Research Advocate | Consultant Clinical Oncologist

About (MJOCS)

Welcome to the Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) — a globally accessible, peer-reviewed platform committed to advancing the frontiers of oncology research, clinical cancer care, and translational discoveries in the fight against cancer..